QUALITATIVE AND QUANTITATIVE COMPOSITION

Adrenalin tartarate (equivalent to a 1,0 mg of adrenalin)	1,8 mg
Excipient q.b.p.	1,0 ml

TARGET ANIMAL SPECIES
Canine, feline, equine, bovine, ovine and birds.

Local administration:
Preventive and temporary homeostatic in arterioles and capillaries at the level of mucous membranes and subcutaneous surfaces, during chirurgical interventions, being particularly indicated in dental extractions and in epistaxis.

Systemic administration:
Bronchitic asthma and reversible broncospasms, due to the broncodilatator effect;
Emergency treatment of acute anaphylactic reactions, namely anaphylactic shock;
Cardiac arrest, severe bradicardia, hypotension, complete or partial A-V blockade and Stokes-Adams syndrome;
In association with local anaesthetic, it diminishes his absorption and extends his action.

DOSAGE AND ADMINISTRATION
The solution is administrated by parentheric, intra-venous, intra-muscular, and intra-cardiac route. 

WAITING TIME
Nil.

PRESENTATION
Package with 10 blisters of 2 ml.

QUALITATIVE AND QUANTITATIVE COMPOSITION

Lidocaine chloridrate	20mg
Water to injectables q.b.p.	1ml

TARGET ANIMAL SPECIES
Equine, bovine, caprine, ovine and dogs.

THERAPEUTICAL INDICATIONS
Anestesin is indicated for several forms of local or regional anaesthetics, namely anaesthetic for nervous blockade, epidural anaesthetic and regional intravenous anaesthetic.

DOSAGE AND ADMINISTRATION
Injectable solution for application for the following ways of administration: SC, IM, IV and epidural.

WAITING TIME
Nil.

PRESENTATION
Containers of 50 ml.

QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose (2ml) contains:

Epsilon anatoxin Clostridium perfringens, type D	≥ 5 UI
Anatoxin and anaculture Clostridium perfringens, type A	≥ 1 UI
Anaculture Clostridium sordelli	100% protection
Pasteurella multocida, type I (Roberts)	4,2 x 109 cells

TARGET ANIMAL SPECIES
Bovine, ovine and goats.

THERAPEUTICAL INDICATIONS
Active immunization against Enterotoxaemia, namely pulpy kidney disease (Clostridium perfringens, type D), gaseous gangrene (Clostridium perfringens, type A, and Clostridium sordelli) and Pasteurellosis (Pasteurella multocida, type I Roberts).

Posology, DOSAGE AND ADMINISTRATION
The vaccine is applied subcutaneously in the following doses:
1st vaccination:

Lambs and kids	2 ml
Adult sheep and goats	3 to 5 ml
Bovines	5 to 10 ml

2nd vaccination:
Three or four weeks after
Revaccination:
annual

WAITING TIME
Nil.

PRESENTATION
Containers of 50 ml and 250 ml.

QUALITATIVE AND QUANTITATIVE COMPOSITION

Glucose	0,3 g
Water for injectables q.b.p.	1,0 ml

TARGET ANIMAL SPECIES
Bovine, equine, swine, ovine, goats, rabbits, dogs and cats.

THERAPEUTICAL INDICATIONS
It’s destined for the correction of dehydration situations, protein tissue catabolism and hepatic glycogen deficiency. It’s indicated in the cases of water and food ingestion restriction (pre and post operative periods, gastro-intestinal diseases), in the normalization of salt excess caused for great water loss, in sodium diuresis caused by overdosing of electrolytic solutions, in the prevention and treatment ketosis by starvation, and in the treatment of hyperpotassaemia.

Posology, DOSAGE AND ADMINISTRATION
The dosage to be administrated will depend on the organic needs and it is in the dependency of the veterinary surgeon criteria. In general, the indicated applications are of 1000 to 4000 ml in 24 hours.
It’s administrated exclusively by slow intravenous way. The velocity of administration must not surpass 60 drops per minute.

WAITING TIME
Nil.

PRESENTATION
Containers of 500 ml and 1000 ml.

QUALITATIVE AND QUANTITATIVE COMPOSITION

Glucose	0,05 g
Water for injectables q.b.p.	1 ml

TARGET ANIMAL SPECIES
Bovine, equine, swine, ovine, goats, dogs and cats.

THERAPEUTICAL INDICATIONS
The glucosoro isotónico is destined to the correction of situations of true dehydration (resulting from water loss without loss of salts), hypoglycaemic or hyper caloric states, protein tissue catabolism, nutrition in the pre and post operative, and gastro-intestinal diseases, as hepatic protector, in the prevention and therapeutic of ketosis, and as vehicle for salutions of other medical products.

Posology, DOSAGE AND ADMINISTRATION
The dosage to be administrated will depend on the organic needs and it is in the dependency of the veterinary surgeon criteria. It’s administrated exclusively by slow intravenous way. The velocity of administration must not surpass 60 drops per minute.

WAITING TIME
Nil.

PRESENTATION
Containers of 500 ml and 1000 ml.